ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,829.20
0.06%
Gold vs US Dollar
2,422.49
-0.16%
Brent Oil
82.895
-0.76%
Bitcoin
69,754.08
-2.37%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Phaxiam Therapeutics (0QSS) Share Price

0QSS Phaxiam Therapeutics

71.025
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Phaxiam Therapeutics LSE:0QSS London Stock Exchange Ordinary Share FR001400K4B1 PHAXIAM THERAPEUTICS ORD SHS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 71.025 6.925 7.28 0.00 0.00  10 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.33M -23.49M -0.3866 -183.70 4.31B
 Type  Size  Price  Time  Units 
  9 3.07 07:00:25 EUR
 
Recent News
DateTimeSource
HeadlineMore 0QSS News
15/05/202416:45GLOBEPHAXIAM provides Business and Financial Update for the First Quarter of 2024
15/05/202416:45GLOBEPHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024
03/05/202417:05GLOBEInformation mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024
03/05/202417:05GLOBEMonthly information related to total number of voting rights and shares composing the share capital – April 30, 2024
15/04/202406:30GLOBEPHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus
15/04/202406:30GLOBEPHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureus
09/04/202417:00GLOBEMonthly information related to total number of voting rights and shares composing the share capital – March 29, 2024
Period
Draw mode
Data Downloads for 0QSS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Phaxiam Therapeutics
Get quick technical analysis for Phaxiam Therapeutics.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.


Loading Follow Feed...

Latest Phaxiam Therapeutics Articles